- Cytiva completing 1. 6 billion USD in strategic investments to . . .
Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several locations in the United States, Europe, and Asia as part of its ongoing commitment to enhancing delivery for customers developing and manufacturing advanced therapeutics
- Cytiva 2025 Company Profile: Valuation, Funding Investors . . .
Information on valuation, funding, cap tables, investors, and executives for Cytiva Use the PitchBook Platform to explore the full profile
- Cytiva outlines $1. 6bn facility investment plans through 2028
By August 2025, the lines will boost the production capacity for filter membranes for North America by 20% Also in North America, the company is increasing access to cell culture media by expanding its dry powder and liquid media manufacturing capacity in Logan, Utah, for large volumes
- Cytiva invests $1. 6B in global manufacturing capacity with an . . .
In the U S , Cytiva is increasing access to cell culture media by expanding dry powder and liquid media manufacturing capacity in Logan, Utah, for large volumes and adding high-speed bottle filling for small volumes
- Cytiva US LLC - Dun Bradstreet
Contact us to understand how D B calculated your company’s specific ESG Ranking, provide new or updated information to ensure your company’s ESG Ranking remains accurate and up to date, or dispute your current ranking
- Document - SEC. gov
For the fourth quarter 2021, revenues increased 20 5% year-over-year to $8 1 billion, with 19 5% non-GAAP core revenue growth For the full year 2021, net earnings were $6 3 billion, or $8 50 per diluted common share which represents a 74 0% year-over-year increase
- Cytiva expanding US operations
Cytiva, a global life sciences leader, is investing in additional resins manufacturing operations outside of Sweden, for the first time in the company’s history, with the acquisition of a new facility in Muskegon, Michigan
|